Diagnosis, treatment, and prevention of gout.
Hainer BL, Matheson E, Wilkes RT.
Am Fam Physician. 2014 Dec 15;90(12):831-6.
Secondary gout.
GARDNER FH, NATHAN DG.
Med Clin North Am. 1961 Sep;45:1273-82. doi: 10.1016/s0025-7125(16)33834-2.
Gout Keratitis: A Case of Peripheral Ulcerative Keratitis Secondary to Gout With a Review of the Literature.
Yazdanyar A, Rizzuti AE, Mechel E, Denisova K, Lazzaro DR.
Cornea. 2018 Mar;37(3):379-381. doi: 10.1097/ICO.0000000000001415.
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.
N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373.
Hyperuricemia and gout.
Lioté F.
Curr Rheumatol Rep. 2003 Jun;5(3):227-34. doi: 10.1007/s11926-003-0072-y.
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares.
Saag KG, Khanna PP, Keenan RT, Ohlman S, Osterling Koskinen L, Sparve E, Åkerblad AC, Wikén M, So A, Pillinger MH, Terkeltaub R.
Arthritis Rheumatol. 2021 Aug;73(8):1533-1542. doi: 10.1002/art.41699. Epub 2021 Jul 7.
Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin.
McCormick N, Yokose C, Lu N, Wexler DJ, Aviña-Zubieta JA, De Vera MA, McCoy RG, Choi HK.
JAMA Intern Med. 2024 Jun 1;184(6):650-660. doi: 10.1001/jamainternmed.2024.0376.
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
McCormick N, Yokose C, Lu N, Wexler DJ, Aviña-Zubieta JA, De Vera MA, Chigurupati S, Tan K, Chen C, McCoy R, Curhan GC, Choi HK.
BMJ. 2024 Oct 30;387:e080035. doi: 10.1136/bmj-2024-080035.
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W.
Lancet. 2018 Oct 20;392(10156):1403-1412. doi: 10.1016/S0140-6736(18)32158-5.
Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials.
Yang XH, Zhang BL, Cheng Y, Fu SK, Jin HM.
Ann Med. 2024 Dec;56(1):2332956. doi: 10.1080/07853890.2024.2332956. Epub 2024 May 13.
